Clinical
New clinical trial registered for Setmelanotide
Related compound: SetmelanotideView source →
Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a) (NCT07496463) registered on ClinicalTrials.gov. Phase: phase 2. Status: not yet recruiting.